Kay Olmstead

This inventor holds 19 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Intercept Pharmaceuticals, Inc., Santarus, Inc., Tocagen Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kay Olmstead. Retrieved from https://idiyas.com/inventor/kay-olmstead

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 10)

% Patents Active = 94.7

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 37(Granted Patents)

Location History:

Escondido, CA (US) (2018 - 2021)
San Diego, CA (US) (2014 - 2023)

Company Filing History:

4 out of 62

Intercept Pharmaceuticals, Inc.

Mingsight Pharmaceuticals, Inc.

patents

5. 2 out of 2

Nano Pharmasolutions, Inc.

patents

6. 2 out of 15

Novmetapharma Co., Ltd.

Novmetapharma Co., Ltd.

patents

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Therapeutic Agent

Nanoparticles

Polymorphic Forms

Cyclo (-His-Pro)

CRAC Channel Inhibitors

PKC Inhibitor

5-Fluorocytosine

Obeticholic Acid

Acid Secretion

Pharmaceutical Formulations

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12616659 - Therapeutic agent nanoparticles and methods of preparation (2026-05-05),

2. 12534496 - Polymorphic forms of Cyclo (-His-Pro) and methods of use to treat kidney disease (2026-01-27),

3. 12522589 - Synthesis of CRAC channel inhibitors (2026-01-13),

4. 12415807 - PKC inhibitor solid state forms (2025-09-16),

5. 12370145 - Therapeutic agent nanoparticles and methods of preparation (2025-07-29),

6. 11820834 - Polymorphic forms of Cyclo (-His-Pro) and methods of use to treat kidney disease (2023-11-21),

7. 11191764 - Formulations of 5-fluorocytosine and uses thereof (2021-12-07),

8. 11104679 - PKC inhibitor solid state forms (2021-08-31),

9. 10758549 - Compositions of obeticholic acid and methods of use (2020-09-01),

10. 10751349 - Compositions of obeticholic acid and methods of use (2020-08-25),

11. 10683300 - Polymorphic forms of Cyclo (-His-Pro) (2020-06-16),

12. 10646499 - Compositions of obeticholic acid and methods of use (2020-05-12),

13. 10449194 - Formulations of 5-fluorocytosine and uses thereof (2019-10-22),

14. 10052337 - Compositions of obeticholic acid and methods of use (2018-08-21),

15. 9889133 - Formulations of 5-fluorocytosine and uses thereof (2018-02-13),

Title: Kay Olmstead - Innovative Inventor from San Diego

Introduction: Kay Olmstead is a pioneering inventor based in San Diego, California, known for her groundbreaking contributions to various fields.

Latest Patents: Kay Olmstead holds several patents in the areas of sustainable energy solutions, medical devices, and consumer electronics.

Career Highlights: With a career spanning over two decades, Kay Olmstead has been at the forefront of innovation, consistently pushing the boundaries of technology and design. Her work has garnered recognition for its creativity and practicality.

Collaborations: Throughout her career, Kay Olmstead has collaborated with leading research institutions, universities, and companies to bring her inventions to life. Her ability to work across disciplines has led to the development of cutting-edge products that have made a significant impact on society.

Conclusion: Kay Olmstead's passion for innovation and her dedication to creating solutions for real-world problems have solidified her reputation as a visionary inventor in San Diego and beyond.

Profile summary based on public USPTO records.